Vliyanie tabakokureniya na zdorov'e i massu telacheloveka
https://doi.org/10.14341/2071-8713-5273
Abstract
Tobacco smoking causes a lot of human deseases and is one of the main reasons of premature death. Smoking cessation is very
important for the patient's health but difficult for them due to development of nicotine dependence. Tobacco dependence is a chronic
disease. Smoking Cessation Clinical Practice Guideline, published in 2008, emphasize the dire health consequences of tobacco dependence,
regulate the way of treating patients who want to quit smoking, recommending the use of effective treatments, including counseling
and medications. Seven first-line medications (5 nicotine and 2 non-nicotine, including Varenicline) that reliably increase long-term
smoking abstinence rates are now available. Smoking cessation is accompanied by a moderate weigh gain. And its a strong motivational
factor to continue smoking, espcially for women. Сounseling, healthy food and physical activity are recommended for such patients.
important for the patient's health but difficult for them due to development of nicotine dependence. Tobacco dependence is a chronic
disease. Smoking Cessation Clinical Practice Guideline, published in 2008, emphasize the dire health consequences of tobacco dependence,
regulate the way of treating patients who want to quit smoking, recommending the use of effective treatments, including counseling
and medications. Seven first-line medications (5 nicotine and 2 non-nicotine, including Varenicline) that reliably increase long-term
smoking abstinence rates are now available. Smoking cessation is accompanied by a moderate weigh gain. And its a strong motivational
factor to continue smoking, espcially for women. Сounseling, healthy food and physical activity are recommended for such patients.
References
1. Доказательная эндокринология: [руководство] /Под ред. Камачо П., Гариба Х., Сайзмора Г.; пер. с англ. под ред. Мельниченко Г.А., Рожинской Л.Я. - 2-е изд., испр. и доп. М.: ГЭОТАР-Медиа, 2009; 35-36.
2. Погосова Г.В., Ахмеджанов Н.М., Качанова Н.П., Колтунов И.Е. Современные принципы медикаментозного лечения табакокурения и никотиновой зависимости // Профилактическая медицина 2009; 5: 29-34.
3. Смирнова Н.В., Пояркова Н.А. Эффективность и безопасность варениклина (Чампикса) при отказе от курения // Клиническая фармакология и терапия 2010; 19 (1): С. 1-4.
4. Сахарова Г.М., Антонов Н.С. Вредное воздействие табакокурения на здоровье и подходы к лечению табачной зависимости // Справочник поликлинического врача 2008; 14/15: С. 14-18.
5. Сахарова Г.М., Чучалин А.Г. Лечение табачной зависимости // Русский медицинский журнал 2001; 5: С. 168-172.
6. Чижова О.Ю., Болдуева С.А., Шабров А.В. Опыт применения варениклина (Чампикса) в лечении табачной зависимости у больных ХОБЛ // Клиническая фармакология и терапия 2010; 19 (1): С. 5-6.
7. Benowitz N.L. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction // Clin. Pharmacol. Ther. 2008; 83(4): P 531-41.
8. Chatkin R. Smoking and changes in body weight: can physiopathology and genetics explain this association? // JMJ Bras. Pneumol. 2007; 33(6): P 712-9.
9. Eisenberg D., Quinn B.C. Estimating the effect of smoking- cessation on weight gain: an instrumental variable approach // Health. Serv. Res. 2006; 41: P 2255-66.
10. Ferrara C.M., Kumar M., Nicklas B., et al. Weight gain and adipose tissue metabolism after smoking cessation in women // Int. J. Obes. Relat. Metab. Disord. 2001 Sep.; 25(9): P. 1322-6.
11. Filozof C., Fernandez-Pinilla M.C., Fernandez-Cruz A. Smoking cessation and weight gain // Obes. Rev. 2004; 5: P 95-103.
12. Fiore M., Jaen C., Baker T. et al. A Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 Update // American Journal of Preventive Medicine 2008; P 35(2).
13. Gunnell D., Irvine D., Wise L., Davies C., Martin R.M. Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database // BMJ 2009; 339: b3805.
14. Hajek P. Introduction: Recognition and management of some possible consequences of stopping smoking // Curr. Med. Res. Opin. 2009; 25(2): P 509-510.
15. Lee H., Joe K.H., Kim W., Park J., Lee D.H., Sung K.W., Kim D. Increased leptin and decreased ghrelin level after smoking cessation // J. Neurosci Lett 2006; 409(1): P 47-51.
16. Pisinger C., Jorgensen T. Waist circumference and weight following smoking cessation in a general population // Prev. Med. 2007; 44: P 290-5.
17. Rolemma H., Guanowsky V., Mineur Y.S. Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect // Eur. J. Pharmacol. 2009; 605 (1-3): P 114-116.
18. Shelley D., Cantrell J., Faulkner D. et al. Physician and dentist tobacco use counseling and adolescent smoking behavior: results from the 2000 National Youth Tobacco Survey // Pediatrics 2005; 115: P 719-25.
19. The health consequences of smoking. Surgeon General's report. U.S. Department of Health and Human Services. Atlanta, GA, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.
20. Vielwerth S.E., Jensen R.B., Larsen T. et al. The impact of maternal smoking on fetal and infant growth // Early Hum. Dev. 2007; 83: P 49-5.
21. Wahl S.K., Turner L.R., Mermelstein R.J. et al. Adolescents' smoking expectancies: psychometric properties and prediction of behavior change // Nicotine Tob. Res. 2005; 7: P 613-23.
Review
For citations:
, , Vliyanie tabakokureniya na zdorov'e i massu telacheloveka. Obesity and metabolism. 2010;7(1):15-19. (In Russ.) https://doi.org/10.14341/2071-8713-5273
Views:
545
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
